What does Takeda Pharmaceutical do?
Table of Contents
What does Takeda Pharmaceutical do?
Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine.
What drugs does Takeda manufacture?
A
- ACTOS (pioglitazone)
- ACTOplus met (pioglitazone and metformin HCl)
- ACTOplus met XR (Discontinued) [pioglitazone and metformin HCl (extended release)]
- ADDERALL XR® (mixed salts of a single-entity amphetamine)
- ADVATE® [Antihemophilic Factor (Recombinant)]
- ADYNOVATE® [Antihemophilic Factor (Recombinant), PEGylated]
Is Takeda Pharmaceutical a buy?
3 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Takeda Pharmaceutical in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should “hold” Takeda Pharmaceutical stock.
What is Takeda’s biggest drug?
Entyvio
In fiscal year 2020, the leading product in terms of sales of the Japanese pharmaceutical company Takeda Pharmaceutical Co., Ltd. was Entyvio, with a sales value of more than 429.3 billion Japanese yen. Entyvio is a prescription drug treating adult patients with ulcerative colitis and Crohn’s disease.
Why is Takeda stock so low?
Shares of Japanese pharmaceutical company Takeda Pharmaceutical (NYSE: TAK) were down by more than 10% as Wednesday’s closing bell neared, following the company’s decision to prematurely stop a key drug trial due to safety concerns.
Is Takeda stock undervalued?
Valuation metrics show that Takeda Pharmaceutical Co. may be undervalued. Its Value Score of A indicates it would be a good pick for value investors. The financial health and growth prospects of TAK, demonstrate its potential to outperform the market.
Is Takeda a Fortune 500?
As Takeda makes Fortune’s Global 500 for the second consecutive year, Takeda’s President and CEO Christophe Weber speaks with Fortune’s Alan Murray about our global transformation, innovative R&D pipeline and focus on purpose-led sustainability. Watch here.
What is the biggest pharmaceutical company in Japan?
Astellas Pharma Inc
Top 15 pharma companies in Japan
| # | Company | Growth (%) |
|---|---|---|
| 1 | Astellas Pharma Inc | 15.34% |
| 2 | Takeda Pharmaceutical Co Ltd | 7.82% |
| 3 | Daiichi Sankyo Co Ltd | 5.34% |
| 4 | Mitsubishi Tanabe Pharma Corp | 10.57% |
How big is Takeda Pharmaceuticals?
It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following its merger with Shire). The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year.
